CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union
Go back to CHMP recommends revoking marketing authorisation for TAVNEOS® (avacopan) in the European Union| CARLISLE COMPANIES, Inc. (NYSE: CSL) | Delayed: 360.74 -4.98 (1.36%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $365.72 | 52 Week High | $114.49 | |||
| Open | $361.99 | 52 Week Low | $75.17 | |||
| Day High | $366.02 | P/E | 99.93 | |||
| Day Low | $359.46 | EPS | $3.61 | |||
| Volume | 340,849 | |||||
| (AMEX: CSLLY) | Delayed: 31.34 +0.34 (1.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.00 | 52 Week High | $45.60 | |||
| Open | $31.15 | 52 Week Low | $33.39 | |||
| Day High | $31.43 | P/E | N/A | |||
| Day Low | $31.00 | EPS | $0.00 | |||
| Volume | 102,987 | |||||
